Rare diseases
Investigational molecules
Locations
147 conditions with trials, the busiest first
548 trials across Europe, recruiting first
Study on ITI-1284 for Treating Psychosis in Alzheimer's Patients
BulgariaStudy of Light Therapy and Melatonin for Treatment of Major Depressive Episode with Insomnia
FranceStudy on the Effects of Semaglutide on Mood in Patients with Major Depressive Disorder and Overweight or Obesity
DenmarkStudy of TAK-360 tablets to evaluate safety and effectiveness in people with Idiopathic Hypersomnia
FranceStudy of levetiracetam to prevent seizures in adults who have both Down syndrome and Alzheimer's disease
SpainLong-Term Study on the Safety and Effects of ALKS 2680 for Patients with Narcolepsy Type 1 and Type 2
BelgiumStudy on How Methylphenidate Works in Adults with ADHD, Comparing Those with and Without Obesity
FranceStudy on the Effects of Cannabidiol and Naltrexone on Alcohol Craving in Patients with Alcohol Dependence
GermanyStudy on Brain Activity in Treatment-Resistant Depression Using [18F]MC225 for Patients with Depression
ItalyStudy on Melatonin and Quetiapine for Treating Insomnia in Adolescents with Psychiatric Disorders
DenmarkStudy on the Effects of Tirzepatide on Reducing Alcohol Intake in Patients with Schizophrenia and Alcohol Use Disorder
DenmarkTitle: Evaluation of lorazepam, pregabalin, and olanzapine in treating agitated behavior in dementia patients who did not respond to standard treatments
The NetherlandsThe therapies tested most often in Psychiatric disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
